Pulmonary Or Respiratory Drug Delivery Global Market Report 2026
상품코드:1957720
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 250 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
폐 및 호흡기 약물전달 시장 규모는 최근 현저한 성장을 이루고 있습니다. 2025년 756억 7,000만 달러에서 2026년에는 822억 3,000만 달러에 이르고, CAGR 8.7%로 성장할 전망입니다. 지난 수년간의 성장에는 천식 및 COPD(만성폐쇄성폐질환) 유병률 증가, 흡입기 보급 확대, 호흡기 전문병원 증가, 에어로졸 기술의 발전, 재택치료 확대 등이 요인으로 꼽힙니다.
폐·호흡기 약물전달 시장 규모는 향후 몇 년간 강력한 성장이 전망됩니다. 2030년에는 1,142억 3,000만 달러에 이르고, CAGR은 8.6%를 나타낼 전망입니다. 예측 기간의 성장 요인으로는 고령화, 대기오염 노출 증가, 디지털 흡입기 보급 확대, 재택의료 환경의 확대, 만성 호흡기 질환 증가 등을 꼽을 수 있습니다. 예측 기간 동안 주요 동향으로는 흡입 기반 약물 전달의 채택 증가, 재택 호흡 요법에 대한 수요 증가, 건식 분말 흡입기 및 정량 분무식 흡입기 사용 증가, 만성 호흡기 질환 관리 확대, 환자 친화적 전달 장치에 대한 관심 증가 등이 있습니다.
폐렴 발병률 증가는 향후 몇 년 동안 폐 및 호흡기 약물 전달 시장의 성장을 견인할 것으로 예측됩니다. 폐렴은 폐의 감염성 질환으로 폐포의 염증을 유발하는 질환입니다. 이로 인해 폐포가 체액과 고름으로 채워져 기침, 발열, 호흡곤란 등의 증상이 나타납니다. 폐렴 증가 요인으로는 고령화, 면역기능 저하, 호흡기 감염, 대기오염, 흡연, 항생제 내성균의 출현 등을 들 수 있습니다. 폐-호흡기 약물 전달은 항생제, 기관지 확장제, 항염증제 등의 약물을 폐에 직접 전달하여 폐렴 환자를 돕습니다. 이를 통해 증상 완화, 염증 감소, 감염 제거, 호흡 기능 개선을 목표로 신속하고 효과적인 치료가 가능해 회복 촉진 및 합병증 예방에 도움이 됩니다. 예를 들어, 2024년 12월 영국에 본사를 둔 임상연구 뉴스 플랫폼 Clinical Trials Arena가 보고한 바에 따르면, 2023년 10월부터 2024년 2월까지 마이코플라즈마 폐렴으로 인한 입원 환자 수가 461% 증가하여 110건에서 617건으로 늘어났습니다고 합니다. 로 증가했습니다. 이 중 0-4세 소아에서 20.2%, 5-9세 소아에서 25.4%, 10-14세 소아에서 17.5%의 폐렴이 확인되었으며, 보고된 650건 중 410건이 해당 연령대에 해당합니다. 그 결과, 폐렴 증가 추세는 폐 및 호흡기 영역의 약물 전달 시장을 주도하고 있습니다.
폐-호흡기 영역의 약물 전달 시장에서 사업을 전개하는 주요 기업들은 치료 효과와 환자의 복약 순응도를 향상시키는 첨단 약물 전달 시스템 등 기술 혁신에 집중하고 있습니다. 첨단 약물전달시스템은 치료제의 표적 전달과 제어된 방출을 가능하게 하는 첨단 기술로, 약물의 성능과 환자의 치료 결과를 향상시키는 기술입니다. 예를 들어, 2023년 7월에는 제네릭 및 브랜드 의약품을 제조하는 미국 헬스케어 기업 Viatris Inc.와 약물 전달을 전문으로 하는 미국 기업 Kindeva Drug Delivery L.P.가 미국 식품의약국(FDA)의 승인을 받아 승인받은 흡입용 에어로졸 제제 'Breyna(부데소니드 및 포모테롤 푸마르산염 이수화합물) 흡입용 에어로졸'을 출시했습니다. 이 제품은 아스트라제네카의 심비코트(R)의 첫 번째 제네릭 의약품으로 천식 및 만성폐쇄성폐질환(COPD) 치료에 사용되는 부데소니드와 포르모테롤을 혼합한 정량 분무형 흡입기입니다. 80마이크로그램과 160마이크로그램의 두 가지 용량으로 제공되며, 호르몬테롤은 4.5마이크로그램이 함유되어 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 공급망 분석
제4장 세계 시장 동향과 전략
제5장 최종 이용 산업 시장 분석
제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의의 공급망에 대한 영향, 코로나 팬데믹이 시장에 미치는 영향을 포함한 거시경제 시나리오
제7장 세계 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석
제8장 TAM(Total Addressable Market) 규모
제9장 시장 세분화
제10장 지역별/국가별 분석
제11장 아시아태평양 시장
제12장 중국 시장
제13장 인도 시장
제14장 일본 시장
제15장 호주 시장
제16장 인도네시아 시장
제17장 한국 시장
제18장 대만 시장
제19장 동남아시아 시장
제20장 서유럽 시장
제21장 영국 시장
제22장 독일 시장
제23장 프랑스 시장
제24장 이탈리아 시장
제25장 스페인 시장
제26장 동유럽 시장
제27장 러시아 시장
제28장 북미 시장
제29장 미국 시장
제30장 캐나다 시장
제31장 남미 시장
제32장 브라질 시장
제33장 중동 시장
제34장 아프리카 시장
제35장 시장 규제 상황과 투자환경
제36장 경쟁 구도와 기업 개요
제37장 기타 주요 기업 및 혁신 기업
제38장 세계 시장 경쟁 벤치마킹과 대시보드
제39장 주요 인수합병(M&A)
제40장 시장 잠재력이 높은 국가, 부문, 전략
제41장 부록
LSH
영문 목차
영문목차
Pulmonary or respiratory drug delivery involves administering medication directly into the lungs to ensure rapid absorption, focused treatment, and minimized systemic side effects, providing both local and systemic therapeutic benefits.
The primary categories of pulmonary or respiratory drug delivery are based on formulation type and device type. Formulation type refers to the method of preparing drugs to ensure effective administration, accurate dosing, and proper absorption in the body. The different canister types include plain canisters and coated canisters. These are utilized for various applications such as chronic obstructive pulmonary disease, asthma, cystic fibrosis, and other conditions. They are also employed by different end-users, including hospitals, clinics, and home care settings.
Tariffs have affected the pulmonary drug delivery market by increasing the cost of imported devices, propellant canisters, and formulation components used in inhalation therapies. The impact is most visible in inhaler and nebulizer segments, where device precision and component availability are critical. Regions such as Asia Pacific and Europe have experienced higher input costs due to reliance on cross border medical device supply chains. Rising tariff related expenses have influenced product pricing, procurement decisions, and launch timelines. However, tariffs have supported local device manufacturing, encouraged innovation in inhalation technologies, and strengthened regional production ecosystems over the long term.
The pulmonary or respiratory drug delivery market research report is one of a series of new reports from The Business Research Company that provides pulmonary or respiratory drug delivery market statistics, including pulmonary or respiratory drug delivery industry global market size, regional shares, competitors with a pulmonary or respiratory drug delivery market share, detailed pulmonary or respiratory drug delivery market segments, market trends and opportunities, and any further data you may need to thrive in the pulmonary or respiratory drug delivery industry. This pulmonary or respiratory drug delivery market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The pulmonary or respiratory drug delivery market size has grown strongly in recent years. It will grow from $75.67 billion in 2025 to $82.23 billion in 2026 at a compound annual growth rate (CAGR) of 8.7%. The growth in the historic period can be attributed to rising asthma and copd prevalence, widespread inhaler adoption, growth in respiratory hospitals, improved aerosol technologies, expansion of homecare treatments.
The pulmonary or respiratory drug delivery market size is expected to see strong growth in the next few years. It will grow to $114.23 billion in 2030 at a compound annual growth rate (CAGR) of 8.6%. The growth in the forecast period can be attributed to aging population, rising air pollution exposure, growth in digital inhalers, expansion of homecare settings, increasing chronic respiratory conditions. Major trends in the forecast period include rising adoption of inhalation-based drug delivery, increasing demand for home-based respiratory therapies, growing use of dry powder and metered dose inhalers, expansion of chronic respiratory disease management, increased focus on patient-friendly delivery devices.
The rising prevalence of pneumonia is expected to drive the growth of the pulmonary or respiratory drug delivery market in the coming years. Pneumonia is a lung infection that causes inflammation of the air sacs, which may fill with fluid or pus, resulting in symptoms such as cough, fever, and difficulty breathing. Factors contributing to the increasing prevalence of pneumonia include aging populations, weakened immune systems, respiratory infections, air pollution, smoking, and the emergence of antibiotic-resistant bacteria. Pulmonary or respiratory drug delivery assists pneumonia patients by directly targeting the lungs with medications, including antibiotics, bronchodilators, or anti-inflammatory agents, allowing for faster and more effective treatment to relieve symptoms, reduce inflammation, eliminate infections, and improve respiratory function, ultimately supporting recovery and preventing complications. For example, in December 2024, Clinical Trials Arena, a UK-based clinical research news platform, reported that hospital admissions for Mycoplasma pneumoniae rose by 461% from October 2023 to February 2024, increasing from 110 to 617 admissions, with 20.2% of pneumonia cases detected in children aged 0 to 4 years, 25.4% in children aged 5 to 9 years, and 17.5% in children aged 10 to 14 years, accounting for 410 of the 650 cases reported. Consequently, the growing prevalence of pneumonia fuels the pulmonary or respiratory drug delivery market.
Major companies operating in the pulmonary or respiratory drug delivery market are concentrating on technological innovations such as sophisticated drug delivery systems that improve treatment effectiveness and patient adherence. Sophisticated drug delivery systems are advanced technologies that facilitate targeted delivery and controlled release of therapeutic agents, enhancing drug performance and patient outcomes. For example, in July 2023, Viatris Inc., a US-based healthcare company that produces generic and branded medications, and Kindeva Drug Delivery L.P., a US-based firm specializing in drug delivery, launched Breyna (budesonide and formoterol fumarate dihydrate) Inhalation Aerosol, an inhalation aerosol approved by the Food and Drug Administration, a US government agency. This is the first generic version of AstraZeneca's Symbicort and a metered-dose inhaler combining budesonide and formoterol for the treatment of asthma and chronic obstructive pulmonary disease. It is offered in two strengths of 80 micrograms and 160 micrograms with 4.5 micrograms of formoterol.
In January 2025, Molex LLC, a US-based electronic solutions provider and parent company of Phillips-Medisize, acquired Vectura Group Ltd. for an undisclosed amount. Through this acquisition, Molex intends to strengthen Phillips-Medisize's pulmonary and respiratory drug delivery capabilities by incorporating Vectura's advanced inhalation device technologies, supporting the development of next-generation inhalation therapies and broadening its global product portfolio. Vectura Group Ltd. is a UK-based provider of inhalation drug delivery systems with a strong history of innovation in respiratory therapy devices.
Major companies operating in the pulmonary or respiratory drug delivery market are Merck & Co. Inc., Novartis AG, Thermo Fisher Scientific Inc., AstraZeneca plc, Abbott Laboratories, 3M Company, Koninklijke Philips N.V., GlaxoSmithKline, Omron Corporation, Teva Pharmaceutical Industries Ltd., Aptar Pharma, Sumitomo Pharma America Inc., Chiesi Farmaceutici S.p.A., Cipla Inc., Boehringer Ingelheim GmbH, Kindeva Drug Delivery Limited, Nemera Group, Hovione, H And T Presspart Group, Vectura Group plc
North America was the largest region in the pulmonary or respiratory drug delivery market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pulmonary or respiratory drug delivery market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the pulmonary or respiratory drug delivery market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The pulmonary or respiratory drug delivery market consists of sales of metered-dose inhalers (MDIs), dry powder inhalers (DPIs), nebulizers, aerosol formulations, and smart inhalers. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Pulmonary Or Respiratory Drug Delivery Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses pulmonary or respiratory drug delivery market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on end user analysis.
Benchmark performance against key competitors based on market share, innovation, and brand strength.
Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for pulmonary or respiratory drug delivery ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The pulmonary or respiratory drug delivery market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Scope
Markets Covered:1) By Product: Formulation Type; Device Type
2) By Canister Type: Plain Canister; Coated Canister
3) By Application: Chronic Obstructive Pulmonary Disease; Asthma; Cystic Fibrosis; Other Applications
4) By End-User: Hospitals; Clinics; Home Care Settings
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report
+ Excel Dashboard
Added Benefits
Bi-Annual Data Update
Customisation
Expert Consultant Support
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.
4.2.1 Rising Adoption Of Inhalation-Based Drug Delivery
4.2.2 Increasing Demand For Home-Based Respiratory Therapies
4.2.3 Growing Use Of Dry Powder And Metered Dose Inhalers
4.2.4 Expansion Of Chronic Respiratory Disease Management
4.2.5 Increased Focus On Patient-Friendly Delivery Devices
5. Pulmonary Or Respiratory Drug Delivery Market Analysis Of End Use Industries
5.1 Hospitals
5.2 Clinics
5.3 Home Care Settings
5.4 Specialty Respiratory Centers
5.5 Ambulatory Care Centers
6. Pulmonary Or Respiratory Drug Delivery Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market
7. Global Pulmonary Or Respiratory Drug Delivery Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis
7.1. Global Pulmonary Or Respiratory Drug Delivery PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
7.2. Global Pulmonary Or Respiratory Drug Delivery Market Size, Comparisons And Growth Rate Analysis
7.3. Global Pulmonary Or Respiratory Drug Delivery Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
7.4. Global Pulmonary Or Respiratory Drug Delivery Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)
8. Global Pulmonary Or Respiratory Drug Delivery Total Addressable Market (TAM) Analysis for the Market
8.1. Definition and Scope of Total Addressable Market (TAM)
8.2. Methodology and Assumptions
8.3. Global Total Addressable Market (TAM) Estimation
8.4. TAM vs. Current Market Size Analysis
8.5. Strategic Insights and Growth Opportunities from TAM Analysis
9. Pulmonary Or Respiratory Drug Delivery Market Segmentation
9.1. Global Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Formulation Type, Device Type
9.2. Global Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Canister Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Plain Canister, Coated Canister
9.3. Global Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Chronic Obstructive Pulmonary Disease, Asthma, Cystic Fibrosis, Other Applications
9.4. Global Pulmonary Or Respiratory Drug Delivery Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Hospitals, Clinics, Home Care Settings
9.5. Global Pulmonary Or Respiratory Drug Delivery Market, Sub-Segmentation Of Formulation Type, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
9.6. Global Pulmonary Or Respiratory Drug Delivery Market, Sub-Segmentation Of Device Type, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Inhalers (Manual and Digital), Nebulizers (Compressor, Ultrasonic, Mesh), Breath-Activated Devices, Spacer Devices, Nasal Drug Delivery Devices
10. Pulmonary Or Respiratory Drug Delivery Market Regional And Country Analysis
10.1. Global Pulmonary Or Respiratory Drug Delivery Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
10.2. Global Pulmonary Or Respiratory Drug Delivery Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
11. Asia-Pacific Pulmonary Or Respiratory Drug Delivery Market
11.1. Asia-Pacific Pulmonary Or Respiratory Drug Delivery Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
11.2. Asia-Pacific Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Segmentation By Canister Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
12. China Pulmonary Or Respiratory Drug Delivery Market
12.1. China Pulmonary Or Respiratory Drug Delivery Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
12.2. China Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Segmentation By Canister Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
13. India Pulmonary Or Respiratory Drug Delivery Market
13.1. India Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Segmentation By Canister Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
14. Japan Pulmonary Or Respiratory Drug Delivery Market
14.1. Japan Pulmonary Or Respiratory Drug Delivery Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
14.2. Japan Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Segmentation By Canister Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
15. Australia Pulmonary Or Respiratory Drug Delivery Market
15.1. Australia Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Segmentation By Canister Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
16. Indonesia Pulmonary Or Respiratory Drug Delivery Market
16.1. Indonesia Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Segmentation By Canister Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
17. South Korea Pulmonary Or Respiratory Drug Delivery Market
17.1. South Korea Pulmonary Or Respiratory Drug Delivery Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
17.2. South Korea Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Segmentation By Canister Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
18. Taiwan Pulmonary Or Respiratory Drug Delivery Market
18.1. Taiwan Pulmonary Or Respiratory Drug Delivery Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
18.2. Taiwan Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Segmentation By Canister Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
19. South East Asia Pulmonary Or Respiratory Drug Delivery Market
19.1. South East Asia Pulmonary Or Respiratory Drug Delivery Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
19.2. South East Asia Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Segmentation By Canister Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
20. Western Europe Pulmonary Or Respiratory Drug Delivery Market
20.1. Western Europe Pulmonary Or Respiratory Drug Delivery Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
20.2. Western Europe Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Segmentation By Canister Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
21. UK Pulmonary Or Respiratory Drug Delivery Market
21.1. UK Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Segmentation By Canister Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
22. Germany Pulmonary Or Respiratory Drug Delivery Market
22.1. Germany Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Segmentation By Canister Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
23. France Pulmonary Or Respiratory Drug Delivery Market
23.1. France Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Segmentation By Canister Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
24. Italy Pulmonary Or Respiratory Drug Delivery Market
24.1. Italy Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Segmentation By Canister Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
25. Spain Pulmonary Or Respiratory Drug Delivery Market
25.1. Spain Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Segmentation By Canister Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
26. Eastern Europe Pulmonary Or Respiratory Drug Delivery Market
26.1. Eastern Europe Pulmonary Or Respiratory Drug Delivery Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
26.2. Eastern Europe Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Segmentation By Canister Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
27. Russia Pulmonary Or Respiratory Drug Delivery Market
27.1. Russia Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Segmentation By Canister Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
28. North America Pulmonary Or Respiratory Drug Delivery Market
28.1. North America Pulmonary Or Respiratory Drug Delivery Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
28.2. North America Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Segmentation By Canister Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
29. USA Pulmonary Or Respiratory Drug Delivery Market
29.1. USA Pulmonary Or Respiratory Drug Delivery Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
29.2. USA Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Segmentation By Canister Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
30. Canada Pulmonary Or Respiratory Drug Delivery Market
30.1. Canada Pulmonary Or Respiratory Drug Delivery Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
30.2. Canada Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Segmentation By Canister Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
31. South America Pulmonary Or Respiratory Drug Delivery Market
31.1. South America Pulmonary Or Respiratory Drug Delivery Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
31.2. South America Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Segmentation By Canister Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
32. Brazil Pulmonary Or Respiratory Drug Delivery Market
32.1. Brazil Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Segmentation By Canister Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
33. Middle East Pulmonary Or Respiratory Drug Delivery Market
33.1. Middle East Pulmonary Or Respiratory Drug Delivery Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
33.2. Middle East Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Segmentation By Canister Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
34. Africa Pulmonary Or Respiratory Drug Delivery Market
34.1. Africa Pulmonary Or Respiratory Drug Delivery Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
34.2. Africa Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Segmentation By Canister Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
35. Pulmonary Or Respiratory Drug Delivery Market Regulatory and Investment Landscape
36. Pulmonary Or Respiratory Drug Delivery Market Competitive Landscape And Company Profiles
36.1. Pulmonary Or Respiratory Drug Delivery Market Competitive Landscape And Market Share 2024
36.1.1. Top 10 Companies (Ranked by revenue/share)
36.2. Pulmonary Or Respiratory Drug Delivery Market - Company Scoring Matrix
36.2.1. Market Revenues
36.2.2. Product Innovation Score
36.2.3. Brand Recognition
36.3. Pulmonary Or Respiratory Drug Delivery Market Company Profiles
36.3.1. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
36.3.2. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
36.3.3. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
36.3.4. AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis
36.3.5. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
37. Pulmonary Or Respiratory Drug Delivery Market Other Major And Innovative Companies
3M Company, Koninklijke Philips N.V., GlaxoSmithKline, Omron Corporation, Teva Pharmaceutical Industries Ltd., Aptar Pharma, Sumitomo Pharma America Inc., Chiesi Farmaceutici S.p.A., Cipla Inc., Boehringer Ingelheim GmbH, Kindeva Drug Delivery Limited, Nemera Group, Hovione, H And T Presspart Group, Vectura Group plc
38. Global Pulmonary Or Respiratory Drug Delivery Market Competitive Benchmarking And Dashboard
39. Key Mergers And Acquisitions In The Pulmonary Or Respiratory Drug Delivery Market
40. Pulmonary Or Respiratory Drug Delivery Market High Potential Countries, Segments and Strategies
40.1 Pulmonary Or Respiratory Drug Delivery Market In 2030 - Countries Offering Most New Opportunities
40.2 Pulmonary Or Respiratory Drug Delivery Market In 2030 - Segments Offering Most New Opportunities
40.3 Pulmonary Or Respiratory Drug Delivery Market In 2030 - Growth Strategies
